Minnesota HF 1183: Excessive drug price increases prohibited by manufacturers to generic or off-patent drugs, attorney general authorized to take action against manufacturers for price increases, withdrawal of generic or off-patent drug sales prohibited, and civil penalties imposed.

Status: Author stricken Boe (as of 2021-04-09)

State: Minnesota · Session: 2021-2022 · Bill: HF 1183

Subjects: Drugs and Medicine, Health and Health Department

Sponsors: Stephenson, Bierman, Greenman, Klevorn

View Minnesota HF 1183 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.